WHY WE NEED THE BABY TIME STUDY
70% of women with breast cancer are recommended hormone therapy for up to 10 years following active treatment. For these women, the very same treatments that reduce the risk of a recurrence are contraindicated with pregnancy. This means a young woman who is diagnosed at age 30 could be 40 by the time she can safely try to start having a family.
Rethink Breast Cancer is asking you to help fund the international Baby Time (POSITIVE) clinical trial in Canada to provide answers for future generations of young women who wish to interrupt their endocrine therapy to try to have a baby and evaluate the safety of doing so.
WHERE THE MONEY GOES
More than 60 breast cancer centres in 20 countries around the world are participating in the Baby Time study. Rethink Breast Cancer has committed to raising $100,000+ over the next 4 years to run the Canadian research arm of this study. But we can’t do it without your help!
We need to raise $25,000 by March 2016 so that breast cancer centres across Canada can begin enrolling patients. Money raised beyond this will be used to enroll additional women ongoing over the next four years.
It costs approximately $3,000 for each woman to participate in the trial.
This includes all start up costs to get the study up and running with Health Canada and the Research Ethics Board as well as:
- recruitment and enrollment
- nursing staff costs
- data collection, analysis and reporting
- personalized care by dedicated medical team
- coordination of data with all participating centres
- follow up of each participant for up to 10 years*
- providing the Canadian data to the international centre
*Each woman will be guided through taking a break from their endocrine therapy (3 months), attempting pregnancy (up to 2 years) and then monitored (up to 10 years) to track possible recurrence of breast cancer.